Lambert-Eaton myasthenic syndrome is caused by antibodies against small-cell lung cancer cells, damaging voltage-gated calcium channels on presynaptic terminals in motor neurones, leading to weakness in proximal muscles and affecting intraocular, levator, and pharyngeal muscles causing symptoms like diplopia, ptosis, slurred speech, and dysphagia